• Childhood Kidney Diseases
• /
• 제8권1호
• /
• pp.80-85
• /
• 2004

저자들은 급성 호흡곤란을 주소로 내원하여 반복적 심낭삼출로 2차례 심막천자술을 시행하였으나 심증상이 지속되다가 이후 발생한 임상적 소견과 혈액검사로 전신성 홍반성 낭창을 진단하여 부신피질호르몬을 투여한 후 심증상의 뚜렷한 호전을 보인 11세 여환아를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

• Tuberculosis and Respiratory Diseases
• /
• 제54권4호
• /
• pp.429-438
• /
• 2003

배 경 : 후기 ARDS로 스테로이드를 투여 받은 환자들에서 어느 시점까지의 반응의 유무가 기계환기에서의 이탈 여부를 예측할 수 있는지 시간경과에 따른 생리학적 지표의 변화를 기준으로 살펴보았다. 방 법 : 1999년 12월부터 2002년 7월까지 내과계 중환자실에서 ARDS로 7일 이상 기계환기치료를 받은 후에도 심한 저산소증($PaO_2/FIO_2$ ratio<200)이 지속되어 스테로이드 치료를 시행하였던 28명(남 : 여 24 : 4, 중앙연령 64세)을 대상으로 후향적 연구를 시행하였다. 스테로이드는 Meduri 등의 방법을 사용하여 투여하였다. 스테로이드 투여 후 기계환기에서 이탈이 가능하였던 환자들을 이탈군(n=14)으로, 기계환기 중 사망하였거나 이탈에 실패했던 환자들을 실패군(n=14)으로 나누어 기저특성과 기계환기 시작일(Dmv), 스테로이드 투여 3일전(D-3), 투여 당일(D0), 그리고 투여 후 3일(D3), 7일(D7)의 생리학적 지표들을 비교하였다. 결 과 : 이탈군과 실패군 사이의 기저특성상의 유의한 차이는 발견되지 않았으며 Dmv과 D-3에 두 군간에 생리학적 지표들의 차이는 없었다(p>0.05). D0에는 이탈군의 다장기부전 점수(SOFA score)가 6.6+/-2.5로 실패군의 8.8+/-2.9보다 유의하게 낮았다(p<0.05). 투여 D7에는 폐유순도를 제외한 대부분의 지표들이 두 군간 유의한 차이를 보였으며(p<0.05), 이탈군에서는 D0에 비해 생리학적 지표들이 유의한 호전이 있었던 반면에 실패군에서는 유의한 호전이 관찰되지 않았다. 결 론 : 결론적으로 후기 ARDS에서 스테로이드 투여 후 7일까지 생리학적 지표의 호전을 보이지 않는 경우 스테로이드 치료 지속 여부를 신중히 고려해야 할 것으로 생각한다.

• Clinics in Shoulder and Elbow
• /
• 제17권2호
• /
• pp.50-56
• /
• 2014

Background: To assess the clinical outcomes of short-term oral corticosteroid therapy for impingement syndrome of the shoulder and determine whether it can be substituted as an alternative to the intra-articular injection. Methods: The clinical outcomes of the 173 patients, the oral steroid group (n=88) and the injection group (n=85), were measured at 3 weeks, 2, 4, and 6 months postoperatively. The clinical outcomes were assessed by measuring the the University of California at Los Angeles (UCLA) score, visual analog scale (VAS) and range of motion (ROM) at every follow-up. Any complications and recurrence rate were noted. A relationship between the treatment outcomes and factors such as demographic factors, clinical symptoms and radiographic findings were determined. Results: No difference was observed in VAS and UCLA scores between the two groups, but forward flexion and internal rotation of ROM were significantly improved in the injection group at the 2nd and 4th postoperative month (p < 0.05). At 6th postoperative month, recurrence rate of symptoms was 26% in the oral steroid group and 22% in the injection group. No major adverse effects were observed. When the clinical outcomes of the oral steroid group were compared to either demographic, clinical symptoms, or radiographic findings, UCLA score was found to be significantly low (p < 0.05) in patients with joint stiffness and UCLA score, whereas VAS score was significantly improved in patients with night pain (p < 0.05). Conclusions: Short-term low-dose oral corticosteroid therapy of impingement syndrome showed comparable clinical outcomes to intra-articular injection without any remarkable adverse effects. Low-dose oral steroids can be regarded as a partial alternative to intra-articular injection for the initial therapy of impingement syndrome of the shoulder.

• 대한간학회지
• /
• 제24권4호
• /
• pp.430-435
• /
• 2018

Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.

• Mycobiology
• /
• 제40권2호
• /
• pp.124-128
• /
• 2012

Multiple treatment modalities, including topical and systemic corticosteroid and phototherapy, have been used in treatment of patients with atopic dermatitis. However, long-term corticosteroid therapy may have various adverse effects. The purpose of this study was to investigate the therapeutic efficacy and safety of bath therapy using green tea extracts for treatment of patients with atopic dermatitis. A total of four patients with atopic dermatitis were enrolled in this study. A Malassezia multiplex detection kit was used in performance of multiplex PCR on clinical isolates, which confirmed Malassezia sympodialis. Subjects underwent treatment with bath therapy using green tea extracts three times per wk for a period of 4 wk. Assessment using the scoring atopic dermatitis (SCORAD) index, the visual analogue scale for pruritus, and transepidermal water loss was performed weekly. Laboratory tests were performed before and after treatment. All patients showed marked improvement on the mean SCORAD and visual analogue scale, and a significant decrease in the mean values of serum eosinophil counts was observed after treatment. Bath therapy with green tea extract is an effective, safe, and nonsteroidal therapy for treatment of patients with atopic dermatitis associated with Malassezia sympodialis.

• 대한치과의사협회지
• /
• 제11권3호
• /
• pp.191-194
• /
• 1973

The Authors have observed a case of hypopituitary patient in 15 year-old Korean child for 10 months. Since he was discharged, he was taken the hormonal therapy with corticosteroid and T₃. As the result of it, his body weight increased by 1.2kg and height grew by 3cm. However it is not clear whether this growth is due to the child's natural growth or due to the above hormonal therapy.

• The Korean Journal of Pain
• /
• 제2권2호
• /
• pp.198-202
• /
• 1989

우측 암면부, 특히 안구주위에 심한 통증을 호소하고 안검하수와 더불어 우측안구의 완전마비를 동반한 선천성 난장이 환자를 경험하였던 바 이는 신경방사선과학적소견, 검사실 검사소견, 전신적 corticosteroid치료에 대한 반응이 전형적인 Tolosa-Hunt Syndrome과는 다른 비전형적인 Tolosa-Hunt Syndrome이었기에 문헌적 고찰과 함께 보고하는 바이다.

• 한국임상약학회지
• /
• 제30권2호
• /
• pp.102-112
• /
• 2020

Objective: To analyze the prescription patterns for the treatment of ulcerative colitis (UC) and to investigate factors co-occurring with systemic corticosteroid use. Methods: We used patient-level data from Korean National Health Insurance claims database to identify patients diagnosed with UC (ICD-10 code : K51) and their medications prescribed for UC between January 1 and Decemeber 31, 2017. We found that medications for UC treatment were 5-aminosalicylic acid (5-ASA), immunomodulators, biologics, and corticosteroids. We presented the prescription pattern according to the sex, age group, type of health insurance, site of UC, type of medical institution, and concomitant medication. To evaluate factors associated with prescription of systemic corticosteroids for UC, we used a multivariate logistic regression model to estimate adjusted odds ratios (aORs) and their 95% confidence intervals (CIs). Results: Of 1,469 UC patients, 74.5% used 5-ASA and 15.2% used systemic corticosteroids. 5-ASA constituted 77.5% of all prescriptions and systemic corticosteroids accounted for 13.1%. The most widely used therapy was 5-ASA monotherapy (54.8%), followed by a double therapy with 5-ASA and immunomodulators (8.2%) or 5-ASA and systemic corticosteroids (7.2%). Systemic corticosteroids were more likely to be prescribed with immunomodulators (aOR=1.88, 95% CI=1.54-2.28) and biologics (aOR=2.82, 95% CI=2.28-3.50) than without them. Conclusions: We found that 15.2% of UC patients were prescribed with a systemic corticosteroid, which is less than reported previously. Systemic corticosteroids were more likely to be prescribed with immunomodulators and biologics.

• Archives of Plastic Surgery
• /
• 제38권6호
• /
• pp.879-882
• /
• 2011

Purpose: Superior orbital fissure syndrome is a rare neurological complex. Superior orbital fissure syndrome may result from a variety of inflammatory, infectious, neoplastic, iatrogenic, traumatic, vascular cause. The author report a patient who suffered from superior orbital fissure syndrome after inferior orbital wall reduction. Methods: A 26-year-old female suffered from inferior orbital wall fracture with inferior gaze limitation and orbital soft tissue herniation. On posttrauma 10 day, inferior orbital wall was reduced using endoscope and porous polyethylene ($Medpor^{(R)}$) was inserted. On immediate postoperation, she reported that extraocular movement was limited in almost any directions. She underwent exploration surgery to release the presence of extraocular muscle impingement. But, there was no observation of extraocular muscle impingement. On postoperative one day, high-dose steroid therapy was started to release superior orbital fissure syndrome which was defined in postoperative computed tomography. Results: After one month of high-dose steroid therapy, extraocular movement limitations improved progressively in all directions. In four months, extraocular movement recovered completely. Conclusion: Superior orbital fissure syndrome may occur after surgical procedure of orbital wall reduction. Prompt diagnosis and treatment with mega-dose corticosteroid is an effective option for avoiding disaster from compressive syndrome.

• Childhood Kidney Diseases
• /
• 제5권2호
• /
• pp.210-212
• /
• 2001

망막박리증은 소아에서는 드물게 발생하는 질환이나 스테로이드를 사용한 환아에서 장액성 망막박리가 발생한 경우가 국내외에서 종종 보고되고 있다. 신증후군으로 전신적 스테로이드를 사용하던 환아에서 양안에 열공성 망막박리가 발생하여 우안에는 레이저 치료를 좌안에는 공막돌륭술을 시행하였던 1례가 있어 보고하는 바이다.